Patents by Inventor Daniel Rixson

Daniel Rixson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICALLY ACCEPTABLE SALTS OF PSILOCIN AND USES THEREOF
    Publication number: 20240124398
    Abstract: The present invention composition features pharmaceutically acceptable salts of psilocin and compositions thereof. The pharmaceutically acceptable salts of psilocin may be used to treat a disease or condition, such as a neurological injury, an inflammatory condition, chronic pain, or a psychological condition, in a subject in need thereof.
    Type: Application
    Filed: February 10, 2022
    Publication date: April 18, 2024
    Inventors: David E. NICHOLS, Graham JOHNSON, Hooshang S. ZAVAREH, Claire WOMBWELL, Daniel RIXSON, Peter HADDOW, Carrie SHEARD, Alexander SCHWARZ
  • PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOSITIONS THEREOF
    Publication number: 20240101514
    Abstract: Pharmaceutically acceptable salts of 5-methoxy-N,N-dimethyltryptamine are described, as well as compositions/formulations and uses thereof as a medicament.
    Type: Application
    Filed: August 4, 2023
    Publication date: March 28, 2024
    Applicant: BECKLEY PSYTECH LIMITED
    Inventors: Jason GRAY, Susana DEL RIO GANCEDO, Dita DAVIS, David James PEARSON, Daniel RIXSON
  • PHARMACEUTICALLY ACCEPTABLE SALTS OF PSILOCIN AND USES THEREOF
    Publication number: 20230357144
    Abstract: The present invention composition features pharmaceutically acceptable salts of psilocin and compositions thereof. The pharmaceutically acceptable salts of psilocin may be used to treat a disease or condition, such as a neurological injury, an inflammatory condition, chronic pain, or a psychological condition, in a subject in need thereof.
    Type: Application
    Filed: May 3, 2023
    Publication date: November 9, 2023
    Inventors: David E. NICHOLS, Graham JOHNSON, Hooshang S. ZAVAREH, Claire WOMBWELL, Daniel RIXSON, Peter HADDOW, Carrie SHEARD, Alexander SCHWARZ
  • Pharmaceutically acceptable salts and compositions thereof
    Patent number: 11773063
    Abstract: Pharmaceutically acceptable salts of 5-methoxy-N,N-dimethyltryptamine are described, as well as compositions/formulations and uses thereof as a medicament.
    Type: Grant
    Filed: September 9, 2022
    Date of Patent: October 3, 2023
    Assignee: Beckley Psytech Limited
    Inventors: Jason Gray, Susana Del Rio Gancedo, Dita Davis, David James Pearson, Daniel Rixson
  • Pharmaceutically acceptable salts of psilocin and uses thereof
    Patent number: 11680043
    Abstract: The present invention composition features pharmaceutically acceptable salts of psilocin and compositions thereof. The pharmaceutically acceptable salts of psilocin may be used to treat a disease or condition, such as a neurological injury, an inflammatory condition, chronic pain, or a psychological condition, in a subject in need thereof.
    Type: Grant
    Filed: March 30, 2022
    Date of Patent: June 20, 2023
    Assignee: Eleusis Therapeutics US, Inc.
    Inventors: David E. Nichols, Graham Johnson, Hooshang S. Zavareh, Claire Wombwell, Daniel Rixson, Peter Haddow, Carrie Sheard, Alexander Schwarz
  • PHARMACEUTICALLY ACCEPTABLE SALTS OF PSILOCIN AND USES THEREOF
    Publication number: 20220289676
    Abstract: The present invention composition features pharmaceutically acceptable salts of psilocin and compositions thereof. The pharmaceutically acceptable salts of psilocin may be used to treat a disease or condition, such as a neurological injury, an inflammatory condition, chronic pain, or a psychological condition, in a subject in need thereof.
    Type: Application
    Filed: March 30, 2022
    Publication date: September 15, 2022
    Inventors: David E. NICHOLS, Graham JOHNSON, Hooshang S. ZAVAREH, Claire WOMBWELL, Daniel RIXSON, Peter HADDOW, Carrie SHEARD, Alexander SCHWARZ
  • Pharmaceutically acceptable salts of psilocin and uses thereof
    Patent number: 11312684
    Abstract: The present invention composition features pharmaceutically acceptable salts of psilocin and compositions thereof. The pharmaceutically acceptable salts of psilocin may be used to treat a disease or condition, such as a neurological injury, an inflammatory condition, chronic pain, or a psychological condition, in a subject in need thereof.
    Type: Grant
    Filed: November 5, 2021
    Date of Patent: April 26, 2022
    Assignee: Eleusis Therapeutics US, Inc.
    Inventors: David E. Nichols, Graham Johnson, Hooshang S. Zavareh, Claire Wombwell, Daniel Rixson, Peter Haddow, Carrie Sheard, Alexander Schwarz